Neoadjuvant Treatment of Locally Advanced HNSCC With Pertuzumab Combined With Lenvatinib.

Clinical trial NCT07550972 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT07550972
Sponsor: Zhejiang Provincial People's Hospital
Status: ENROLLING_BY_INVITATION
Phase: Phase 2
Study type: INTERVENTIONAL

Squamous Cell Carcinoma of the Head and Neck

Start date: 2026-05-01
Primary completion: 2030-03-31
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.